8 сент 2020 г. - • AstraZeneca halts their Phase III vaccine trial due to safety reasons. • The Pfizer-BioNTech partnership expand their Phase III trial by 50% to increase data on safety and efficacy in a more diverse population. Vaccine is administered in 2 shots, 3 weeks apart. Storage conditions are a challenge.
Добавлено на ленту времени:
Дата:
8 сент 2020 г.
Сейчас
~ 3 гг и 8 мес назад
